Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,882 | 759 | 99.1% |
| Education | $119.59 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,082 | 97 | $0 (2024) |
| ABBVIE INC. | $929.42 | 58 | $0 (2024) |
| Amarin Pharma Inc. | $866.19 | 46 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $809.59 | 69 | $0 (2024) |
| Lilly USA, LLC | $732.55 | 46 | $0 (2024) |
| Merck Sharp & Dohme LLC | $699.78 | 58 | $0 (2024) |
| PFIZER INC. | $591.71 | 42 | $0 (2024) |
| Novo Nordisk Inc | $500.55 | 34 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $492.15 | 18 | $0 (2019) |
| GlaxoSmithKline, LLC. | $438.26 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,421 | 62 | AstraZeneca Pharmaceuticals LP ($441.86) |
| 2023 | $1,530 | 85 | AstraZeneca Pharmaceuticals LP ($307.69) |
| 2022 | $1,554 | 99 | Lilly USA, LLC ($158.49) |
| 2021 | $1,935 | 120 | AbbVie Inc. ($462.06) |
| 2020 | $1,578 | 96 | Amarin Pharma Inc. ($486.88) |
| 2019 | $1,458 | 82 | Avanir Pharmaceuticals, Inc. ($362.16) |
| 2018 | $1,703 | 95 | AstraZeneca Pharmaceuticals LP ($245.33) |
| 2017 | $1,823 | 125 | AstraZeneca Pharmaceuticals LP ($240.35) |
All Payment Transactions
764 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/03/2024 | DermaSensor Inc | DermaSensor (Device) | Food and Beverage | Cash or cash equivalent | $39.94 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $130.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Oncology | ||||||
| 09/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/28/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Diabetes Care | ||||||
| 08/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Inflammation | ||||||
| 07/31/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: VACCINE | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Gastroenterology | ||||||
| 07/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Oncology | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Biological | ||||||
| 06/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Bone Health | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,086 | 4,889 | $357,667 | $109,373 |
| 2022 | 19 | 1,356 | 5,312 | $544,414 | $192,046 |
| 2021 | 20 | 1,307 | 8,061 | $584,957 | $229,964 |
| 2020 | 18 | 1,023 | 6,422 | $312,290 | $118,495 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2023 | 33 | 2,760 | $141,360 | $36,056 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 323 | 574 | $105,042 | $34,207 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 161 | 202 | $52,318 | $17,397 | 33.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 91 | 197 | $26,004 | $8,061 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 47 | 47 | $12,408 | $5,377 | 43.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $6,328 | $2,034 | 32.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $4,342 | $1,911 | 44.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 126 | 163 | $978.00 | $958.44 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 44 | 93 | $2,604 | $912.64 | 35.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 20 | $2,240 | $742.50 | 33.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 11 | 12 | $996.00 | $486.60 | 48.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $495.00 | $453.60 | 91.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 15 | 15 | $750.00 | $328.50 | 43.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 30 | $900.00 | $307.80 | 34.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 95 | 619 | $619.00 | $57.72 | 9.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 13 | $195.00 | $44.33 | 22.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 25 | 88 | $88.00 | $38.91 | 44.2% |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | Office | 2022 | 155 | 155 | $108,500 | $50,668 | 46.7% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2022 | 44 | 2,832 | $181,248 | $49,253 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 307 | 533 | $97,539 | $31,669 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 219 | $56,721 | $19,050 | 33.6% |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | Office | 2022 | 40 | 40 | $36,000 | $17,181 | 47.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 100 | 209 | $27,588 | $8,937 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 57 | 57 | $15,048 | $6,672 | 44.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $6,102 | $2,135 | 35.0% |
About Dr. Stephen Badolato, MD
Dr. Stephen Badolato, MD is a Sports Medicine healthcare provider based in Melbourne, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194728832.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Badolato, MD has received a total of $13,002 in payments from pharmaceutical and medical device companies, with $1,421 received in 2024. These payments were reported across 764 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($12,882).
As a Medicare-enrolled provider, Badolato has provided services to 4,772 Medicare beneficiaries, totaling 24,684 services with total Medicare billing of $649,878. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Location Melbourne, FL
- Active Since 05/26/2005
- Last Updated 10/22/2007
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1194728832
Products in Payments
- FARXIGA (Drug) $1,483
- Vascepa (Drug) $866.19
- XARELTO (Drug) $520.10
- UBRELVY (Drug) $501.08
- NUEDEXTA (Drug) $453.06
- Adzenys XR-ODT (Drug) $394.27
- BREZTRI (Drug) $333.71
- ELIQUIS (Drug) $328.80
- JARDIANCE (Drug) $325.04
- JANUVIA (Drug) $296.29
- EMGALITY (Drug) $290.84
- INVOKANA (Drug) $289.49
- CHANTIX (Drug) $250.63
- ENTRESTO (Drug) $241.42
- VOQUEZNA (Drug) $238.44
- Ozempic (Drug) $210.46
- Rybelsus (Drug) $207.47
- VRAYLAR (Drug) $195.54
- Kerendia (Drug) $177.84
- TRINTELLIX (Drug) $177.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Melbourne
Brent Stephens, Md, MD
Sports Medicine — Payments: $29,996
Dr. David Dominguez, M.d, M.D
Sports Medicine — Payments: $11,486
Dr. Brian Hamzavi, M.d, M.D
Sports Medicine — Payments: $11,161
Bharat Patel, Md, MD
Sports Medicine — Payments: $792.17
Jeffrey Westerfield, Md, MD
Sports Medicine — Payments: $158.55
Kelly Kessler
Sports Medicine